Baxter Healthcare has decided to discontinue the distribution of Enlon (edrophonium chloride) 10mg/mL injection in the 15mL multi-dose vial and Enlon-Plus (edrophonium chloride and atropine sulfate) injection in the 5mL ampules and 15mL multi-dose vials. Healthcare providers should consult their suppliers as to the best alternatives for each of these products.

For more information visit http://www.fda.gov/cder/drug/shortages/Enlon.pdf.